Salmonella Enteritidis bacteriophage candidates for phage therapy of poultry by Sillankorva, Sanna et al.
ORIGINAL ARTICLE
Salmonella Enteritidis bacteriophage candidates for phage
therapy of poultry
S. Sillankorva1, E. Pleteneva2, O. Shaburova2, S. Santos1, C. Carvalho1, J. Azeredo1 and V. Krylov2
1 IBB – Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, Universidade do Minho, Campus de Gualtar,
Braga, Portugal
2 State Institute for Genetics and Selection of Industrial Microorganisms, 1st Dorozhnii proezd 1, Moscow, Russia
Introduction
Bacteriophages (phages) are today hypothesized as one of
the possible alternatives to antibiotics in animal therapy,
prophylaxis and reduction of pathogen loads in food prod-
ucts of animal origin. Trials with bacteriophages and farm
animals have proven successful and used to kill foodborne
pathogen such as: Escherichia coli (Smith and Huggins
1983; Smith et al. 1987; Huff et al. 2003, 2006), Salmonella
(Higgins et al. 2005, 2008; O’Flynn et al. 2006; Atterbury
et al. 2007), and Campylobacter (Loc Carrillo et al. 2005;
Wagenaar et al. 2005) among others. Nevertheless, more
studies are still required before phages can be considered a
real approach for therapy of bacterial infections.
The use of phages for therapeutic purposes requires
specific phages for the pathogenic strains of a specific
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Abstract
Aims: Salmonella is a worldwide foodborne pathogen causing acute enteric
infections in humans. In the recent years, the use of bacteriophages has been
suggested as a possible tool to combat this zoonotic pathogen in poultry farms.
This work aims to isolate and perform comparative studies of a group of
phages active against a collection of specific Salmonella Enteritidis strains from
Portugal and England. Also, suitable phage candidates for therapy of poultry
will be selected.
Methods and Results: The Salm. Enteritidis strains studied were shown to have
a significantly high occurrence of defective (cryptic) prophages; however, no
live phages were found in the strains. Bacteriophages isolated from different
environments lysed all except one of the tested Salm. Enteritidis strains. The
bacteriophages studied were divided into different groups according to their
genetic homology, RFLP profiles and phenotypic features, and most of them
showed no DNA homology with the bacterial hosts. The bacteriophage lytic
efficacy proved to be highly dependent on the propagation host strain.
Conclusions: Despite the evidences shown in this work that the Salm. Enteritidis
strains used did not produce viable phages, we have confirmed that some
phages, when grown on particular hosts, behaved as complexes of phages. This
is most likely because of the presence of inactive phage-related genomes
(or their parts) in the bacterial strains which are capable of being reactivated
or which can recombine with lytic phages. Furthermore, changes of the
bacterial hosts used for maintenance of phages must be avoided as these can
drastically modify the parameters of the phage preparations, including host
range and lytic activity.
Significance and Impact of the Study: This work shows that the optimal host
and growth conditions must be carefully studied and selected for the produc-
tion of each bacteriophage candidate for animal therapy.
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environment (Fiorentin et al. 2005; O’Flynn et al. 2006;
Atterbury et al. 2007; Higgins et al. 2008). However, there
are many issues that need to be addressed. Firstly, as a
rule, it is not possible to isolate a single phage capable to
lyse all strains of a particular bacterial species. The use of
wide host range phages could be a hypothesis; however,
in practice, these phages will loose their usefulness after
several applications because of the emergence of phage-
resistant bacterial mutants. There are also ideas of using
hosts, such as safe industrial E. coli strains, for the
production of phages but this also presents practical
disadvantages as the phages capable to overcome interspe-
cies barriers are rare and this makes it practically impossi-
ble to gather a large enough collection of such phages to
compose different phage cocktails. Thus, it will be always
necessary to use different pathogen strains, isolated in the
course of real endemics or infection, for the isolation and
production of phage products and cocktails.
Additionally, for some food pathogens, such as Salmo-
nella, choices of basic hosts among the strains are
required because of a wide occurrence of the restriction–
modification systems. These basic hosts must be non-
lysogenic, and the total collection of isolates needs to be
always checked. Also, the use of basic hosts should opti-
mally result in a good output of the phage.
Finally, there are also some general requirements for
phages to be selected as therapeutic agents, as for
instance: phages must be lytically active for the largest
number of bacterial strains isolated from the specific
areas, and they must be capable of cross lysing ⁄ killing the
phage-resistant variants of each other.
Phage therapy is generally recognized as safe (Bruttin
and Brussow 2005; Xie et al. 2005), but this assumption
cannot be accepted without detailed studies, especially
when considering the use of live therapeutic phages for
long term purposes. So, it is once more emphasized that
for a safe use of phages, the ones capable to lysogenize
bacterial strains or which have DNA homologies with the
chromosome of bacterial hosts are not acceptable.
Salmonella causes acute enteric infections in humans,
and the main routes of transmission of this zoonotic
bacteria to humans are because of the consumption of
contaminated poultry products (eggs, meat) (Lee 1974;
Hird et al. 1993; Henzler et al. 1994; Bryan and Doyle
1995). Poultry carcasses become contaminated with
pathogens when a contaminated flock is processed on the
slaughter line (Mead et al. 1995). Thus, the control of
Salmonella infections at the farm and processing level is
crucial, and the adoption of efficient eradication proce-
dures can decrease the transmission of Salmonella to
humans reducing infections and hospitalizations. This
work describes the isolation, characterization and selec-
tion of suitable Salmonella phages for phage therapy.
Materials and methods
Bacterial strains
Thirty-one Salmonella Enteritidis strains isolated from
contaminated food products in Portugal and from poul-
try farms in England were used for phage isolation and
phage lytic spectrum assessment. Also, seven additional
strains from the Regensburg strain collection (Germany)
were used in the blot hybridization studies. All strains
used (Table 1) were grown at 37C on LB broth or LB
agar (Miller 1972).
Collection bacteriophages
Several Salmonella bacteriophages were provided by the
laboratory of bacteriophage genetics (State Research
Institute for Industrial Microorganisms, Moscow, Russia),
and phage Felix01 was from the Profos AG collection
(Regensburg, Germany) (Table 2).
Verification of bacterial strains for presence of intact
temperate phages
Semi-solid (0Æ6%) LB agar with 50 ll of fresh suspension
of the tested strains was brought on the Petri Dishes with
a layer of normal agarized (1Æ2%) LB medium. The drops
of the same bacteria (after treatment with CHCl3 and
successive centrifugations to remove bacterial debris and
CHCl3) were placed on the lawns. After overnight incuba-
tion, the presence of phage lysis zones or other features
of possible lysis (e.g. bacteriocins) were evaluated in the
drops.
Isolation of new bacteriophages
An enrichment procedure was used for bacteriophage
isolation. Briefly, the enrichment culture flasks (0Æ5 l)
contained 50 ml of 5· concentrated LB nutrient medium,
200 ml of aqueous sample and a mixture of all non-
lysogenic S. Enteritidis strains. The bacterial mixture was
prepared by growth of the Salm. Enteritidis strains, over-
night and at 37C, on agarized LB medium Petri dishes
(15 g of agar per litre of medium). Afterwards, two loops
of each different strain were placed into Eppendorf tubes
with 1 ml of 0Æ9% NaCl, and the tubes were vortexed
1–2 min. Five Hundred microlitres of each of the pre-
pared strain suspensions were mixed in a glass tube. The
mixture (0Æ5 ml) was used to infect culture flasks contain-
ing different samples, and the flasks were incubated
overnight at 37C on shaker (c. 250–400 rev min)1). After
incubation, 1Æ5 ml samples were taken from each of the
flasks into Eppendorf tubes, vortexed with the addition of
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30 ll of CHCl3, centrifuged 2–3 min (12 000 rev min
)1)
to sediment bacterial cells, and debris and drops were
placed on the plates with lawns of the tested bacterial
strains. After overnight incubation at 37C, material was
taken from the lysis spots and was plated on separate
plates with the same bacteria performing dilutions up to
Table 1 Characteristics of the Salmonella Enteritidis used
Strain
Isolation
year Source Country
Phage
type
Antibiotic resistance
N CAZ CIP CN NA AMP S TE
922F 2003 INRJ PT S S S S S S S S
392 1981 INRJ PT S S S S S S S I
Ex1 2004 UB UK 6 S S S S S S S I
550 2003 INRJ PT S S S S S S S I
777 2003 INRJ PT S S S S S S S I
626 1984 INRJ PT S S S S S S S I
629 A 2003 INRJ PT S S S S S S S I
9510-85 Unknown UB UK 8 S S S S S S S R
S 1400 1998 UB UK 4 S S S S S S S R
Ex2 2004 UB UK 6 S S S S S S S R
La5 Unknown UB UK 4 S S S S S S S R
547 2003 INRJ PT S S S S S S S R
855 2004 INRJ PT S S S S S S S R
269 2003 INRJ PT S S S S S S S R
932 1984 INRJ PT S S S S S S S R
905 1984 INRJ PT S S S S S S S R
1067 1990 INRJ PT S S S S S S S R
1649 1992 INRJ PT S S S S S S S R
851 1984 INRJ PT S S S S S S S R
821 2003 INRJ PT S S S S S S S R
126 1981 INRJ PT S S S S S S I R
1188 1996 INRJ PT S S S S S R S R
C6b 2004 UB UK 4 S S S S S R S R
869 2004 INRJ PT S S S S R S S I
856 2003 INRJ PT S S S S R S S I
629 B 2003 INRJ PT S S S S R S S I
696 2002 INRJ PT S S S S R S S I
475 2004 INRJ PT S S S S R S S R
546 2003 INRJ PT S S S S R S S R
583 2003 INRJ PT S S S S R R S I
657 2003 INRJ PT S S S S R R S R
INRJ, Salm. Enteritidis provided by Instituto Nacional Ricardo Jorge; UB, Salm. Enteritidis provided by the Bristol University; S, susceptible; I,
intermediate; R, resistant; N, neomycin (30 lg); CAZ, ceftazadime (30 lg); CIP, ciprofloxacin (5 lg); CN, gentamicin (10 lg); NA, nalidixic acid
(30 lg); AMP, ampicillin (10 lg); S, streptomycin (10 lg); TE, tetracyclin (30 lg).
Table 2 Bacteriophages isolated and collection bacteriophages used
Phage Isolation ⁄ source
Felix01 Profos AG, Regensburg, Germany
uB1 SE5, uB2 SE5, u22, u62, u44, u79, u105, u147, u162,
u164, u171, u177
Phage collection of the State Research Institute for Industrial
Microorganisms, Moscow, Russia
u68, u81 Faeces from Poultry farm 1, Braga, Portugal
u169, u111 Faeces from Poultry farm 2, Braga, Portugal
u31(u31m, u31tu), u38, u39, u135 (u135lar, u135sm), u45 Raw sewage, wastewater treatment plant, Braga, Portugal
u2 (u2a, u2b) Zoo pond, Moscow, Russia
u12 (u12ht) Nests from a Poultry farm, Santiago de Compostela, Spain
u2 ⁄ 2, u4 ⁄ 1(u4 ⁄ 1a, u4 ⁄ 1b), RBS cl, RBS tu, uS151, uA1, uN5, uN4 Wastewater treatment plant, Regensburg, Germany
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single plaques could be seen. Phages with reproducible
plaque type features were reisolated from a single plaque
and plated for confluent lysis (Adams 1959) on several
Petri dishes. After overnight incubation, the phage was
gathered, processed as usual vortexing, centrifugation at
6000 g, 30 min at 4C, CHCl3 treatment and kept in
refrigerator.
The new isolated bacteriophages were designated: RBS
cl, RBS tu, phi 4 ⁄ 1a, phi 4 ⁄ 1b, phi 2 ⁄ 2, phiN4, phiN5,
phi A1, phiB1 SE5, phiB2 SE5 (Table 2).
Purification and concentration of phages in CsCl
preformed gradients
Purification and concentration of phages were accom-
plished as described by Sambrook and Russell (2001).
Phages sensitive to CsCl treatment were concentrated by
precipitation with polyethylene glycol (PEG) ⁄NaCl
(Yamamoto et al. 1970) with the subsequent sedimenta-
tion, resuspension in phage buffer SM (Sambrook and
Russell 2001) and at least two additional cycles of wash-
ing by sedimentation and resuspension. Such preparations
were treated with exonuclease (10 mcg l)1, 1 h at 37C)
to disrupt bacterial DNA and centrifuged 3 h at 40 000 g
to sediment the phage. Finally, phage pellet was resus-
pended in SM buffer.
Isolation of phage DNA, treatment of DNA with
endonucleases, electrophoresis, Southern hybridization
These procedures were performed as described in
Sambrook and Russell (2001).
Antibiotic susceptibility test
The susceptibility of the 31 Salm. Enteritidis isolates to
eight antimicrobial agents was determined by the disc
diffusion method on modified Mueller Hinton II agar
according to the European Committee on Antimicrobial
Susceptibility Testing (EUCAST). The antimicrobial
agents and the respective concentrations (in micrograms)
used are shown in Table 1. The results were interpreted
according to established criteria by the EUCAST (http://
eucast.www137.server1.mensemedia.net/)
Results
This works aim at grouping the isolated phages as a first
step for their classification and at studying the homology
between the DNA, the different phages and bacterial hosts
genomes to exclude all phages capable of enhancing
recombination promoting inclusion into the bacterial
genome genes, which could code pathogenic products.
These are compulsory experiments that need to be
performed to verify phage safety and to select suitable
candidates for therapeutic purposes.
Isolation of phages
Verification of production of intact temperate phages by the
bacterial target hosts
To isolate phages, it was necessary to exclude from the
enrichment experiments evident lysogens, otherwise the
host’s temperate phage(s) would interfere with the interpre-
tation of the results. All 25 Portuguese strains were checked,
and the different strains did not reveal live temperate
phages. Thus, for isolation of new phages, all these strains
were mixed and used together in the enrichment experi-
ments. It was necessary to ensure that the strains used in
the isolation procedure were different. For that all hosts,
isolated from either contaminated foods or animals
(poultry), were tested for their susceptibility towards eight
antibiotics. Based on the antibiotic susceptibility patterns,
the isolates were grouped into nine distinct clusters
(Table 1). Furthermore, the UK isolates have been previ-
ously characterized (Cooper et al. 1994; Cogan et al. 2004),
and therefore their phage type was included in Table 1.
Selection of phages after enrichment procedure
The bacteriophages used in this work were isolated from
different environments and countries (Table 2). All phages
with different plaque types were repeatedly plated to assure
their phenotype stability and phage plaque parameters such
as size, turbid ⁄ clear appearance, edge morphology,
presence of halo around plaques, growth of phage-resistant
bacterial colonies in the lysis spot and estimation of their
number were studied (data not shown). Phages with the
best plaque parameters (clear appearance and the smallest
number of phage-resistant colonies) were chosen for
detailed studies (see bold in Table 2).
Interestingly, the strains used in this work were shown
to be highly sensitive to most of the phages. In fact, the
only strain studied that was resistant to all selected phages
was strain 392.
General comparison of single selected phages on the basis of
their primary features: plaque phenotypes and the growth
on different strains in collection
In this work, a mixture of all nonlysogenic hosts were
used to isolate new phages, to evaluate the effect of the
phage propagation host on the host range, to differentiate
potentially genotypically different phages and include
them in further studies.
Optimal hosts for each potentially different phage were
thus selected, in the course of comparison of phage
growth on different hosts, and the strain which supported
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the phage growth in the best way (larger plaque size,
higher transparency, small number of resistant variants)
was accepted as an optimal host for that particular phage
(data not shown). Also, in comparison with the quality of
phage growth on different hosts, optimal bacterial strains
capable to support the growth of as many as possible
phages in the collection were chosen. An additional
feature which was used to select and differentiate phages
was their plaque appearance. According to the results of
this work, the best strains for differentiation of the phages
used were Ex2 and 9510 (both from the University of
Bristol collection).
Differentiation of the selected phages with RFLP profiles
To have comparable results of the phage RFLPs, most of
the restriction experiments were performed with EcoRV
endonuclease. To simplify the interpretation of results,
they were grouped in several independent experiments.
The DNA digestions of several Salmonella phages were
performed (Figs 1, 2 and 3). The DNA of six digested
phages revealed nonidentical RFLP profiles and phage
u31m showed to be resistant to EcoRV (Fig. 1). However,
there were some evident similarities between these six
phages and their genome sizes, calculated as sums of the
molecular weights of the restrictional fragments, which
varied between 32 and 38 kb. Thus, it can be suggested
that the six EcoRV digested phages, namely u135lar,
u135sm, u38, u169, u68 and u39, may belong to the
same phage group (group 1) while u31m belongs to a
different group.
Phages u2 and u4 ⁄ 1 produced morphologically differ-
ent plaques on their hosts. Therefore, digestions of the
DNA of the two specific variants of each phage (u2a,
u2b, u4 ⁄ 1a and u4 ⁄ 1b) were performed (Fig. 2a). The
digestion profile differed considerably from the ones
obtained after EcoRV digestion of the six phages belonging
to phage group 1 (compare Figs 1 and 2a). Therefore, u2
and u4 ⁄ 1 phages are unrelated from the phages of group
1 and may be considered as presenting two additional
phage groups, groups 2 and 3, respectively. Both variants
of each group, a and b respectively, have a similar restric-
tion profile showing a great number of bands. Despite the
morphological plaque dissimilarity between the two phage
variants (a and b) of each phages u2 and u4 ⁄ 1, their
RFLP profiles cannot be differentiated (Fig. 2a).
f135lar f135m f38 f169 f68 f39 f31M
Figure 1 Digestion of the DNA of different Salmonella phages with
endonuclease EcoRV. Lane M – k HindIII molecular weight marker.
M f2a f2b f4/1a f4/1b f12L f12P M
Figure 2 EcoRV digestion of the DNA of different Salmonella phages.
Lanes M – k HindIII molecular weight marker.
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In this work, a high titre of phage u12 preparation was
purified, concentrated by treating with PEG (see Materials
and methods) and afterwards treated with DNase. After
DNase removal by sedimentation, the DNA was isolated
either directly from the lysate (u12L) or from the single
band obtained after CsCl centrifugation (u12P). As possi-
ble to observe (Fig. 2b), there was a great difference in
the RFPL profiles of both DNAs. Most of the restriction
fragments found in the DNA of phage preparation u12 in
the lysate disappeared after CsCl centrifugation (Fig. 2b).
Also, phage u12 is different from the other phages and
therefore belongs to a different group (group 4).
Phage u2 ⁄ 2 DNA digestion with HindIII was per-
formed after the growth of this phage on two distinct
hosts (1400 and Ex2) (Fig. 3). Phage u2 ⁄ 2 has the biggest
genome among the studied phages which was c. 92–94 kb
as calculated by summing the sizes of the restrictional
fragments. Phage u2 ⁄ 2 grown in both strains, resulted in
equivalent digestions without additional nonequimolar
fragments. Thus, this phage is different from the other
ones found belonging to groups 1–4 and therefore belong
to a new group (group 5).
Besides the DNA of u31m, the DNAs of three other
phages u31tu, uN5 and uA1 were also shown to be resis-
tant to both EcoRV and EcoRI (data not shown). Thus,
these phages may provisionally be considered as different
from the other groups of phages. However, they cannot
be grouped together without further characterization.
Estimation of DNA homology between the selected
phages and between phages and their target bacterial
strains
Homology studies of three different phages were per-
formed. The phages used were phages u169 (group 1),
u4 ⁄ 1 (group 3) and u31tu (so far unassigned group),
respectively. From the studied phages, the DNAs of u169
and u31tu did not show homology with bacterial DNA in
the dot blots (data not shown). The dot blot-hybridiza-
tion of P32 labelled u169 DNA (as zond) with bacterial
and other Salmonella phages DNA was performed
(Fig. 4). According to results obtained, phage u169
revealed DNA homology with nine other phages as
observed by the presence of plaques in the spots of u68,
u39, u135, u38, u2, u45, u79, u81 and u111 but no
relation with other phages.
DNA hybridization of P32 labelled DNA of phage
u31tu showed no homology with bacterial DNAs, but
revealed a good homology with phage uN5 and a trace of
homology with phage u4 ⁄ 1. Furthermore, there was no
homology with any other phages (data not presented).
The hybridization of P32 labelled DNA of phage u4 ⁄ 1
with DNAs of other phages revealed homology with
phages uRBSc1 and uA1 (Fig. 5). It was also observed a
weak DNA homology of u4 ⁄ 1 with DNAs of several of
the tested bacterial strains (data not shown). This may
suggest that phage u4 ⁄ 1 has a higher general input for
defective prophages that are capable to be packed in the
phage particles than all other studied phages. Thus, phage
u4 ⁄ 1 may be considered as a virulent mutant of a
temperate phage, and it has DNA homology with some
M f2/2.S f2/2.Ex21400
Figure 3 HindIII digestion of Salmonella phage u2 ⁄ 2 DNA grown on
Salmonella Enteritidis strains 1400 and Ex2. Lane M – k HindIII
molecular weight marker.
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defective prophage(s), possibly with phage P22 of lambda
group that are common in some of the Salmonella strains
of the studied collection.
The RFLP profile studies together with the study of
DNA hybridizations between phage DNAs permitted the
distribution of all isolated phages in different unrelated
groups. Although RFLP profiles were not performed with
phages u111, u45, u79 and u81, the DNA homology stud-
ies allocate them among the group 1 of phages, together
with phages: u135lar; u135sm; u38; u169; u68 and u39.
The other unrelated phage groups are composed by the
following phages: group 2 consists of phage u2 (variants a
and b); group 3 consists of u4 ⁄ 1, uRBSc1 and uA1; group
4 consists of u12;, group 5 of u2 ⁄ 2 and a new group was
created based on the DNA homology studies which com-
prises phages u31tu and uN5 (group 6).
Overall, of these different phage groups, only phages
belonging to group 3 (u4 ⁄ 1) should not be used for
phage therapy because of the homology with a number of
bacterial strains and the hypothesis of having an input for
defective prophages.
Dependence of growth of the selected phages from their
last host
Considering this possibility, the host range of phages u68
(group 1) and u2 (group 2) was compared (see Table 3).
9510
SE1
269
628
855
1067 1188 1649 2126 12
B1
SE5 SE5
B2 22 45 79 81 111
111
105 2/2 4/1 N5 N4
– f169
f62 f12 fN5 f2/2 f2 f4/1 fA1f151
f31tu f68 f39 f135 m f135lar f38
A1 Felix01
44 162 164 171 177 147
857 858 869 905 922 932
629A 629B 657 696 777 821
392 475 546 547 550 583
SE2 SE3 SE4
C6b
SE5 SE6 SE7
1400 La5 Ex2Ex1
62 2
(a)
(b)Figure 4 Blot hybridization of phage DNA.
(a) u169 phage DNA labelled of P32 (as zond)
with DNAs of other phages (marked with
solid black) and Salmonella strains DNAs
(marked with italic). (b) Blot hybridization of
u169 phage DNA labelled of P32 (as zond)
with DNAs of other phages immobilized on
nylon membrane.
f23 fN5
f62f169 fA1
f2/2f38f31tu
f4/1a
f4/1b f135m
fRBStufRBScl
f2a
f2b
f135lar f12
Figure 5 P32-labelled DNA hybridization of phage u4 ⁄ 1 with other
phage’s DNA.
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To differentiate the origins of phage preparations, gen-
erally accepted designations were used. So, the stock of
phage ‘P’ grown on bacterial strain ‘S1’ will be designated
as ‘P.S1’. Among the phages studied in this work, phage
u2 may have special interest. Table 2 presents the results
of the phage u2 growth characteristics which were propa-
gated on different strains (905, 629B and 9510) and then
tested on the set of all bacterial strains. As can be
observed, all three variants of u2 preparations had slightly
different effects on the set of bacteria used. The best
results for phage u2 were obtained when grown on strain
905 where a clear plaque was observed in a higher
number of strains (Table 3).
The dependence of host range from the last host in
which u68 was grown was also performed (Table 3). The
differences obtained in this study were not as impressive
as the ones obtained with the growth of u2 in distinct
strains; however, it can be observed that phage u68’s
preferred hosts are equally strain Ex2 and 9510 (u68.Ex2
and u68.9510).
Phage u68 grown using strain 932 failed to kill eight
specific strains (see Table 3) that were susceptible
to the phage grown on S. Enteritidis strains Ex2 and
9510.
Also, the effect of host dependence of phage Felix01 on
three distinct hosts (821, 696 and Ex2) was compared
(Table 3). Felix01 grown on strains 821 and Ex2 was
capable of forming plaques on almost all strains tested.
Nevertheless, the lytic efficiency of Felix01 is clearly com-
promised when grown on different host susceptible
strains. For instance, Felix01 growth on strain 696 made
the phage no longer capable of infecting five isolates that
the same phage grown on strain 821 succeeded to attack
(Table 3).
Table 3 Lytic spectra of phages u2, u68 and Felix 01 (F01) grown in different hosts
(Phage name).(Host strain used for growth)
Strain u2.905 u2.629B u2.9510 u68.932 u68.9510 u68.Ex2 F01.821 F01.696 F01.Ex2
922F CL CL CLr CL CLb CLb CLr CLr mix1
392 no no no no no no CLr tur tu
Ex1 CL tu no no tu tu no no mix
550 CL tu no no tu tu tu tu mix
777 CL tu no tu tu tu CLr CLr tu
626 CL CLdb CLr CL CL CL CLr CL tu
629 A CL CLb CLr CL CL CL CLr CLr tu
9510-85 CL CLh CLr CL tuh tuh CLr tu tu
S 1400 CL CL CLr CL CL CL tu no mix
Ex2 CL CL CLr mix2 CLr,h CLr,h tur tur tu
La5 CL CL CLr CL CL CL mix CLr tu
547 CL tu no no tu tu tu no tu
855 CL tu no tu tu tu CLr CL mix
269 CL CLb,lar tur CL CL CL tu CLr tu
932 CL CLh CLr CL CLh CLh tu tu tu
905 CL CLdb,r CLr mix2 CLh CLh tu CL mix
1067 CL CL CLr CL CLb CLb CL tu mix1
1649 CL CLb CLr CL CL CL CLr CLr tu
851 CL CLdb CLr CL CL CLh CLr CL mix
821 CL CLb CLr CL CLh CLh CL CL mix
126 no tu no no tu tr CLr tu tu
1188 tu tu no no tu tu tu no no
C6b CL CL CLr CL CL CL tu no mix1
869 CLb CLdb CLr CLb CLh CLh CLr CL mix
856 CL CLdb CLr CL CLh CLh CL CL mix
629 B CL CL CLr CL CLh CLh CL CL mix
696 CL CLr CLr CL – – CLr CLr CLdb,r
475 mix2 CLb,lar CL mix CLb CLb CLr CLr mix
546 CL CLdb CLr mix2 CLr,h CLr,h CLr CL mix
583 tu tu no no tu tu tur CLr tu
657 tu tu no no tu tu tu tu tu
CL, clear; no, no growth; r, presence of phage resistant colonies; tu, turbid; h, halo around the plaque; b, border of plaque; db, double border of
plaque; mix, mixture of different types of clear and turbid plaques; mix1, mixture of turbid plaques; mix2, mixture of clear plaques; tr, traces of
growth; –, no data; lar, large colony.
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The lytic spectra of phages grown in different hosts
also allowed to distinguish the bacterial isolates used,
because the phage spot patterns on the bacterial lawns of
the nine clusters, grouped according to their resistance
patterns, varied greatly. A closer analysis of the lytic spec-
tra data shows that all 31 tested hosts are different
(Table 3).
Overall, this work shows that to choose the right hosts
for obtaining industrial quantities of phages, it is highly
necessary to perform preliminary studies of restriction–
modification relations among the phages and their target
bacterial strains.
Discussion
Phages are ubiquitous in nature and can be good candi-
dates for use in animal therapy. This work shows that
S. Enteritidis phages are readily isolated and worldwide
distributed and can be efficient in killing bacterial isolates
from different countries.
In this work, for phage isolation, a mixture of all non-
lysogenic hosts was used and therefore it was assumed
that single phage particles would find the most appropri-
ate host in the first or subsequent cycles of growth. This
strategy was adopted because the use of a single bacterial
strain for enrichment not only may be too time consum-
ing but can also lead to the loss of rare phages present in
the sample because of the use of a ‘wrong’ first host.
However, using all bacterial strains in a mixture makes
difficult the identification of which bacterial strains were
the last hosts for each phage. Consequently, some phages
isolated from the initial plantings may present the same
genotypes but may result in a variation in their pheno-
type because of the different host-induced modifications.
Using comparisons of phage host ranges, performing
growth on the same hosts or on several specially selected
common hosts makes possible to differentiate potentially
genotypically different phages and include them in further
studies.
The phages studied here proved to belong to several
different groups. The first group of phages gathers several
closely related phages having genome sizes in the range of
32–38 kbp, sharing DNA homology and several common
restrictional fragments (Fig. 1). DNA isolated from prepa-
ration of phage u2, the second phage group, (Fig. 2a)
had some homology with the DNAs of phages belonging
to the first group. Nevertheless, it was possible that this
preparation included an additional DNA-containing
component.
The third phage group included phage u4 ⁄ 1 with a
broad host range, having traces of homology with bacte-
rial DNA. This last feature does not allow the use of such
phages for the purpose of phage therapy.
Considering that these two phages, u2 and u4 ⁄ 1, and
their respective variants which were obtained from the
same bacterial host, the difference in the number and
location of these additional bands (Fig. 2a) exclude their
origination from bacterial DNA. The only possible expla-
nation for this situation is that phages such as u2 and
u4 ⁄ 1 can specifically induce different defective prophages
in the same bacterial host. Based on the DNA homology
experiments, phages uA1 and also uRBSc1 have homo-
logy to phage u4 ⁄ 1, and therefore these phages were
grouped with this phage.
The fourth phage group includes phage u12 which
has no DNA homology with other phages. It also may
represent a phage complex (or mixture of two phages).
Furthermore, this phage proved to be useful for the
differentiation of bacterial strains. An interesting special
feature of u12 was its great sensitivity to purification
with CsCl because most of the restriction frag-
ments, which were typically present in the total com-
plex, disappeared in u12L. It can be concluded that the
infecting phage u12 activates the development of a
defective prophage whose DNA is being packed into
the phage capsid. However, the defective prophage was
not stable and disrupted in the course of CsCl
treatment.
The fifth phage group comprises only phage u2 ⁄ 2. This
phage has a large genome with nonequimolar restrictional
fragments, a broad host range and no DNA homology
with all other phages. The work described here suggests
that the infection of both strains with phage u2 ⁄ 2 does
not lead to activation of cryptic phage(s), or in the case
that cryptic phage(s) are activated, they were not able to
survive the CsCl gradient centrifugation.
From this study, it is evident that some of the strains
used contain genes which could be packed into the phage
capsids. These results confirm also previous studies
performed with Salmonella sp. (Figueroa-Bossi et al. 1997;
Schicklmaier et al. 1998; Schmieger 1999; Rabsch et al.
2002; Figueroa-Bossi and Bossi 2004; Mikasova´ et al.
2005; Kropinski et al. 2007).
The broad host range phage u31tu showed DNA
homology with uN5, and therefore these phages belong
to group 6. Both phages were shown to have DNA resis-
tant to digestion with EcoRI, EcoRV and HindIII.
The restriction–modification effects are very frequent
in Salmonella sp. Thus, in this study, it was necessary
to work with plenty of unstudied natural bacterial iso-
lates and different newly isolated phages to know the
possible effects of phage movements throughout the dif-
ferent hosts and their consequences in sense of their
influence on phage activity through possible DNA
modifications. The second important reason to check
the ‘effect of the last host’ is because Salmonella
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genomes are known to carry plenty of different live
and ⁄or defective (cryptic) prophages (Figueroa-Bossi
et al. 1997; Schicklmaier et al. 1998; Schmieger 1999;
Rabsch et al. 2002; Figueroa-Bossi and Bossi 2004; Mi-
kasova´ et al. 2005; Kropinski et al. 2007). Therefore,
recombination studies of infection with such phages or
transactivation of such phage by any mechanism can
result in a change of the genetic composition of the
phage preparation and consequent influence on its final
antibacterial activity. Furthermore, the host range of the
different selected bacteriophages (and their possible rela-
tion in the phage grouping attribution) may be inter-
esting for the use of veterinary phage therapy.
Interestingly, in this work, it was observed a change of
the lysis spots into absolutely different ones because of
growth of phages in different hosts, which consequently
altered their lytic spectrum of activity. To exemplify the
importance of the last host and the effect of phage growth
on the phage plaque, a short example will be illustrated.
So, for instance, a droplet of phage u2.629B placed on
the lawn of strain Salmonella 9510 formed a highly trans-
parent spot of lysis with a halo around the plaque while a
droplet of u2.9510 placed on strain 9510 formed a plaque
with a number of resistant colonies. The material from
this spot, now called u2.629B.9510, when plated (after
chloroform treatment) on the same fresh lawn of strain
9510, resulted in an absolutely different lysis spot that
was extremely turbid and filled with phage-resistant cells
(data not shown). One possible explanation for the trans-
formation of, for instance, highly transparent spots with
few resistant colonies, into very turbid spots filled with
phage-resistant cells, as observed in the phage u2 growth
experiments, might be the trans-activation effect of a
defective phage (or bacteriocin) present in this case in the
strain of 629B when the strains was infected. This defec-
tive helper phage will most likely kill bacterial mutants of
strain 9510 that were resistant to u2; however, this helper
phage seemed to disappear as it had no capability to
replicate by itself. This phenomenon explains the high
transparency of the lysis spot and presence of a small
number of resistant colonies. The material taken from the
spot formed on strain 9510 with phage u2.629B does not
contain the active killer substance ⁄ additional defective
phage that was activated in strain 629B, and the Salmo-
nella 9510 strain did not have such transactivated parts in
its genome. So, this work shows that the plaque differ-
ences obtained because of the last host where phage u2
was grown may depend on the transactivation of any
cryptic phage and the consequent package of additional
DNAs in the phage capsids and also on a modification
activity of the last host. Nevertheless, these results clearly
depend on the last bacterial growth host of phage u2.
Consequently, in the final phage lysate, it is most likely
that there are occurring two different killing activities.
According to published results, bacteriophages of S. Ente-
ritidis belong to several groups: P27-like (phage ST64B),
P2-like (Fels-2, SopEphi, and PSP3), lambdoid (Gifsy-1,
Gifsy-2, and Fels-1), P22-like (epsilon34, ES18, P22,
ST104 and ST64T), T7-like (SP6) and three outliers (epsi-
lon15, KS7 and Felix O1) (Kropinski et al. 2007). Thus,
the most frequent prophage components in Salmonella
are different derivatives of P22 or lambda-like phages.
The second phage in a mixed lysate of u2 cannot be
multiplied by itself but it can kill bacterial mutants resis-
tant to u2 (low number of phage-resistant colonies to u2
preparation). Thus, it is possible that the cryptic phage
genome belongs to a virulent phage, because the capabi-
lity to kill bacteria just with adsorption of tail structure is
typical for genuine virulent phages (as an example killing
activity of T2 ghosts) (Herriott and Barlow 1957) or
action of tail-like R2 bacteriocin of Pseudomonas aerugin-
osa (Nakayama et al. 2008). The use of such phenomenon
to increase the activity of phage mixtures can be promis-
ing and advantageous in an industrial scale production:
contributing to a more economic way (as less phages will
be necessary to obtain), saving other phages for future
use and the possibility to use phages giving a high
proportion of phage-resistant cells.
In conclusion, this work shows that the bacterial
hosts need to be specially selected for each phage.
Despite evidence shown that the used bacterial strains
did not produce viable phages, we have confirmed that
some phages, when grown on particular hosts, behave
as complexes of phages. Thus, any change of the bacte-
rial host used for maintenance of phages can drastically
change the parameters of the phage preparations,
including host range and lytic activity. This fact suggests
that the use of phages as prophylactic agents against
Salm. Enteritidis should be avoided to limit the massive
disseminations of phages into natural habitats. Most
importantly, the use of phages should be restricted to
therapeutic purposes.
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